Discussion
The FRAXA Research Foundation has awarded a $100,000 grant to fund a research project that will test Bowen’s FX Therapeutics’ experimental protein-replacement therapies for fragile X syndrome in mice. The newly funded research will be conducted in the laboratory of Devin Binder, MD, PhD, a professor at the…